Medtronic announced CE marks for two new diabetes-care devices: The ZEUS continuous glucose monitor (CGM) sensor, which will be marketed as the Guardian 4, and the InPen insulin pen.
The Guardian 4 is a blood glucose monitor that can be used without fingerstick calibration. The “no-calibration” data that supported Zeus CGM’s CE Mark will be